{"address1": "5858 Horton Street", "address2": "Suite 170", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 318 9098", "website": "https://www.estrellabio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Cheng  Liu Ph.D.", "age": 55, "title": "CEO, President & Director", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jiandong  Xu", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.077, "open": 0.0771, "dayLow": 0.0886, "dayHigh": 0.0886, "regularMarketPreviousClose": 0.077, "regularMarketOpen": 0.0771, "regularMarketDayLow": 0.0886, "regularMarketDayHigh": 0.0886, "beta": -0.09, "volume": 13, "regularMarketVolume": 13, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fiftyTwoWeekLow": 0.0886, "fiftyTwoWeekHigh": 0.0886, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 9097054, "bookValue": -2.89, "netIncomeToCommon": -11114402, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.0886, "recommendationKey": "none", "totalCash": 2479146, "totalCashPerShare": 0.07, "totalDebt": 22000, "quickRatio": 0.254, "currentRatio": 0.282, "returnOnAssets": -1.7475301, "freeCashflow": 2812901, "operatingCashflow": -1336121, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ESLAW", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 15.064939, "regularMarketPrice": 0.0886, "marketState": "PRE", "longName": "Estrella Immunopharma, Inc.", "corporateActions": [], "regularMarketTime": 1743192000, "exchange": "NCM", "messageBoardId": "finmb_1802952199", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.011600003, "regularMarketDayRange": "0.0886 - 0.0886", "fullExchangeName": "NasdaqCM", "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.0886 - 0.0886", "fiftyTwoWeekHighChange": 0.0, "fiftyTwoWeekHighChangePercent": 0.0, "priceToBook": -0.030657439, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "displayName": "Estrella Immunopharma", "trailingPegRatio": null}